None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All persons residing in hotspot areas of covid 19 willing to participate, with or without co- morbid condition with exposure/chance of exposure to COVID 19 positive cases. . Who are willing to provide signed informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant females. 2. Known case of Carcinoma lungs, CRF and CHF. 3. Participants with any immunosuppressive medication or in an immune compromised state or hematological disease. 4. Laboratory confirmed COVID-19 with or without symptoms. 5. DM uncontrolled with medications. 6. Any other criteria, as per the investigator would jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of participants with SARS- Cov-2 positivity and Number/ percentage of participants not developing any Covid-19 like sign & symptoms (Time line 07 days)Timepoint: Percentage of participants with SARS- Cov-2 positivity and Number/ percentage of participants not developing any Covid-19 like sign & symptoms (Time line 07 days) | — |
Secondary
| Measure | Time frame |
|---|---|
| Presence or absence of AE/ADR and their level of tolerability Number of participants who developed any infective diseases during the trial period (bacterial /viral/ fungal / etc.) and percentage of participants with Upper respiratory tract illness during the period. Timepoint: 07 days | — |
Countries
India
Contacts
Dr. S.R. Rajasthan Ayurved University, Jodhpur